Skye Bioscience, Inc. (SKYE)
1.70
-0.08
(-4.23%)
USD |
NASDAQ |
Aug 31, 16:00
1.71
+0.01
(+0.59%)
After-Hours: 16:30
Skye Bioscience Debt to Equity Ratio : -0.3593 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.3593 |
| March 31, 2026 | 0.0345 |
| December 31, 2025 | 0.0137 |
| September 30, 2025 | 0.0098 |
| June 30, 2025 | 0.0084 |
| March 31, 2025 | 0.007 |
| December 31, 2024 | 0.0067 |
| September 30, 2024 | 0.0025 |
| June 30, 2024 | 0.0696 |
| March 31, 2024 | 0.0613 |
| December 31, 2023 | -2.165 |
| September 30, 2023 | 2.598 |
| June 30, 2023 | -0.0352 |
| March 31, 2023 | -0.017 |
| December 31, 2022 | -0.6406 |
| September 30, 2022 | -0.7874 |
| June 30, 2022 | -8.395 |
| March 31, 2022 | 0.836 |
| December 31, 2021 | 0.3642 |
| September 30, 2021 | 0.2401 |
| June 30, 2021 | 0.7348 |
| March 31, 2021 | 0.6614 |
| December 31, 2020 | 3.322 |
| September 30, 2020 | 0.7318 |
| June 30, 2020 | -0.3937 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.3041 |
| December 31, 2019 | 0.7063 |
| September 30, 2019 | -0.201 |
| June 30, 2019 | -0.2665 |
| March 31, 2019 | -0.1046 |
| December 31, 2018 | -0.0875 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | -0.2937 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| April 30, 2014 | 0.4823 |
| January 31, 2014 | 0.4713 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Regeneron Pharmaceuticals, Inc. | 0.0854 |
| Viking Therapeutics, Inc. | 0.01 |
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 11.03M |
| Total Liabilities (Quarterly) | 11.53M |
| Shareholders Equity (Quarterly) | -0.4973M |
| Current Ratio | 0.9504 |
| Net Debt Paydown Yield | 0.19% |